Status:
UNKNOWN
Beclomethasone in Healthy Athletes
Lead Sponsor:
Western Norway University of Applied Sciences
Collaborating Sponsors:
The Norwegian School of Sport Sciences
The Norwegian Doping Control Laboratory
Conditions:
Performance, Detection
Doping
Eligibility:
All Genders
18-35 years
Phase:
PHASE4
Brief Summary
The present study aims to assess her urine concentration of beclomethasone during and after one week of use according to the World Antidoping agency's regulations. The study will assess utility of dri...
Detailed Description
The study is a double-blinded, randomized, controlled parallel trial with participants visiting the laboratory on four separate occasions. The purpose of the first visit is to familiarize the particip...
Eligibility Criteria
Inclusion
- Healthy Maximal oxygen uptake \>60 in male and \>50 in female Signed informed consent.
- \-
Exclusion
- Intention to compete within 3 days after last dose of medicament Asthma diagnosis Use of anti-asthmatic medication last 12 months Upper chest infection last 4 weeks Contraindication to maximal exercise Contraindication to glucocorticoids Pregnancy or possible pregnancy Failure to obtain written informed consent
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05352191
Start Date
September 1 2022
End Date
January 1 2024
Last Update
April 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.